AND Relative Valuation - Andlauer Healthcare Group Inc

Watchlist Manager

Watchlist

Price: 54.97 CAD 0.02% Market Closed

Market Cap: CA$2.2B

A	Andlauer Healthcare Group Inc TSX:AND	CA
	Cincinnati Financial Corp NASDAQ:CINF	US

Relative Value

The Relative Value of one AND stock under the Base Case scenario is 40.01 CAD. Compared to the current market price of 54.97 CAD, Andlauer Healthcare Group Inc is Overvalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

AND Relative Value

Base Case

Overvaluation 27%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CA	A	Andlauer Healthcare Group Inc TSX:AND	2.2B CAD	3.3	31.9	13.4	23.8
US		CVS Health Corp NYSE:CVS	92.5B USD	0.2	52.3	13.6	13.6
US	C	Cigna Group XMUN:CGN	66.4B EUR	0.3	12.9	7.6	9.7
US		Cigna Corp NYSE:CI	70B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.9B EUR	1.1	19.9	9.4	14.1
DE		Fresenius Medical Care AG XMUN:FME	22.3B EUR	1.1	22.8	8.8	16.3
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	24.9	12	17.4
US		Quest Diagnostics Inc NYSE:DGX	21.6B USD	2	21.8	11.8	15.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.6B EUR	0.5	10.9	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	10.9B USD	11.1	-26.2	-28.7	-26.1
US		DaVita Inc NYSE:DVA	10.5B USD	0.8	14.1	7.2	9.8

				Revenue Growth	P/S to Growth
CA	A	Andlauer Healthcare Group Inc TSX:AND	Average P/S: 2 3.3	2%	1.7
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.1	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
CA	A	Andlauer Healthcare Group Inc TSX:AND	Average P/E: 22.3 31.9	7%	4.6
US		CVS Health Corp NYSE:CVS	52.3	90%	0.6
US	C	Cigna Group XMUN:CGN	12.9	19%	0.7
US		Cigna Corp NYSE:CI	11.8	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.9	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	22.8	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	24.9	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.8	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.2	N/A	N/A
US		DaVita Inc NYSE:DVA	14.1	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
CA	A	Andlauer Healthcare Group Inc TSX:AND	Average EV/EBITDA: 9.9 13.4	4%	3.4
US		CVS Health Corp NYSE:CVS	13.6	28%	0.5
US	C	Cigna Group XMUN:CGN	7.6	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.4	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.8	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
CA	A	Andlauer Healthcare Group Inc TSX:AND	Average EV/EBIT: 14.5 23.8	7%	3.4
US		CVS Health Corp NYSE:CVS	13.6	22%	0.6
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.1	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.3	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.1	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

Andlauer Healthcare Group Inc
TSX:AND

Relative Value

Valuation Multiples

Multiples Across Competitors

AND Competitors Multiples
Andlauer Healthcare Group Inc Competitors

See Also

Company

Help

Tools

Stocks

Andlauer Healthcare Group Inc TSX:AND

Relative Value

Valuation Multiples

Multiples Across Competitors

AND Competitors Multiples Andlauer Healthcare Group Inc Competitors

See Also

Company

Help

Tools

Stocks

Andlauer Healthcare Group Inc
TSX:AND

AND Competitors Multiples
Andlauer Healthcare Group Inc Competitors